Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

257 (8%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

3059 (92%)

3327

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

411 (94%)

Reversed:

23 (5%)

436

485 (13%)

28 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-01-12 2023-10-06 180891
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-04-24 249210
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-06-16 2023-07-05 195219
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2021-04-21 2021-05-20 137890
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2018-06-22 2018-10-11 52823
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Actual shortage 2024-06-07 2025-12-02 229963
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-11-14 2023-01-12 174595
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-03-20 249213
DULOXETINE DR 60MG CAPSULE (DELAYED RELEASE) Resolved 2018-03-16 2018-11-08 43119
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2024-12-20 2025-01-18 246254
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2018-12-04 2019-08-06 68608
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-02-17 2023-04-28 185077
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2025-10-23 2025-11-27 270215
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-20 2023-07-05 195784
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-10-19 2023-11-30 207533
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-08 2023-10-03 194144
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2021-02-05 2021-03-11 133445
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
EPTIFIBATIDE INJECTION 2MG SOLUTION Resolved 2017-03-13 2020-02-13 1694
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Resolved 2017-03-13 2020-02-13 1691
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-LORAZEPAM 1MG TABLET Discontinued 2025-05-28 2025-05-28 258513
TEVA-LOSARTAN/HCTZ 50.0MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133902
TEVA-LOSARTAN/HCTZ 100MG 25MG TABLET Discontinued 2021-02-12 2021-02-12 133899
TEVA-LOSARTAN/HCTZ 100MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133896
TEVA-MEDROXYPROGESTERONE 2.5MG TABLET Discontinued 2025-04-29 2025-04-29 256113
TEVA-MEDROXYPROGESTERONE 5MG TABLET Discontinued 2025-04-29 2025-04-29 256116
TEVA-MEDROXYPROGESTERONE 10MG TABLET Discontinued 2025-04-29 2025-04-29 256119
TEVA-METFORMIN 850MG TABLET Reversed 2025-05-28 2025-06-04 258449
TEVA-METFORMIN 500MG TABLET Reversed 2025-05-28 2025-06-04 258452
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258568
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258537
TEVA-METOPROLOL 50MG TABLET Discontinued 2020-07-10 2020-07-10 119976
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Reversed 2025-05-28 2025-06-04 258532
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258535
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MODAFINIL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258732
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055